CTLA4 and osteosarcoma: In this K7M2 metastatic osteosarcoma model, the authors show that α‐PD‐L1 mAb‐treated mice demonstrated an adaptive resistance mechanism in the microenvironment where the tumor or tumor microenvironment may be using CTLA‐4 ligation as an alternative pathway to escape immune destruction.